Marilena Maria de Souza1, Eduardo M Netto2, Maria Nakatani3, Malcolm S Duthie4. 1. Federal University of Campina Grande, Cajazeiras, Paraíba, 58429-900, Brazil. 2. Laboratório de Pesquisa em Infectologia, Federal University of Bahia, Salvador, Bahia, 40110-010, Brazil enetto@ufba.br. 3. Laboratório de Pesquisa em Infectologia, Federal University of Bahia, Salvador, Bahia, 40110-010, Brazil. 4. Infectious Disease Research Institute, Seattle, WA, 98102, USA.
Abstract
BACKGROUND: Despite the widespread use of multidrug therapy, leprosy remains an important public health concern in many regions. Detection is generally limited to clinical exam. METHODS: As a two-tiered active case finding strategy, we used the LID-1 (leprosy IDRI diagnostic-1), and PADL (protein advances for the diagnosis of leprosy) antigens for serological examination of 2526 individuals randomly selected from 10 472 residents in a leprosy hyperendemic area (Cajazeiras, Paraiba, Brazil). Almost all seropositive (95%) and a subset of seronegative (17%) subjects then underwent clinical evaluations. RESULTS: Prevalence of clinically apparent leprosy was 2.3% (19 cases among 834 fully examined individuals). LID-1 and PADL demonstrated a high sensitivity for supporting leprosy diagnosis at 89% and 87%, with positive predictive values (PPV) of 3.5% and 3.7%. The specificity for clinically apparent leprosy was low at 42% and 38%, respectively, and was likely reduced due to the presence of many asymptomatic individuals infected with Mycobacterium leprae. CONCLUSIONS: Our data indicate the utility of the LID-1 and PADL antigens as primary screening tools for the detection of M. leprae infection and identification of leprosy patients. The follow-up of seropositive subjects could clarify the predictive value and utility of detecting anti-LID-1 and PADL antibodies within leprosy control programs.
BACKGROUND: Despite the widespread use of multidrug therapy, leprosy remains an important public health concern in many regions. Detection is generally limited to clinical exam. METHODS: As a two-tiered active case finding strategy, we used the LID-1 (leprosy IDRI diagnostic-1), and PADL (protein advances for the diagnosis of leprosy) antigens for serological examination of 2526 individuals randomly selected from 10 472 residents in a leprosy hyperendemic area (Cajazeiras, Paraiba, Brazil). Almost all seropositive (95%) and a subset of seronegative (17%) subjects then underwent clinical evaluations. RESULTS: Prevalence of clinically apparent leprosy was 2.3% (19 cases among 834 fully examined individuals). LID-1 and PADL demonstrated a high sensitivity for supporting leprosy diagnosis at 89% and 87%, with positive predictive values (PPV) of 3.5% and 3.7%. The specificity for clinically apparent leprosy was low at 42% and 38%, respectively, and was likely reduced due to the presence of many asymptomatic individuals infected with Mycobacterium leprae. CONCLUSIONS: Our data indicate the utility of the LID-1 and PADL antigens as primary screening tools for the detection of M. leprae infection and identification of leprosy patients. The follow-up of seropositive subjects could clarify the predictive value and utility of detecting anti-LID-1 and PADL antibodies within leprosy control programs.
Authors: Pushpendra Singh; Andrej Benjak; Verena J Schuenemann; Alexander Herbig; Charlotte Avanzi; Philippe Busso; Kay Nieselt; Johannes Krause; Lucio Vera-Cabrera; Stewart T Cole Journal: Proc Natl Acad Sci U S A Date: 2015-03-23 Impact factor: 11.205
Authors: Malcolm S Duthie; Maria T Pena; Amit P Khandhar; Alessandro Picone; Zachary MacMIllen; Richard W Truman; Linda B Adams; Steven G Reed Journal: Appl Microbiol Biotechnol Date: 2020-03-10 Impact factor: 4.813
Authors: Angélica da Conceição Oliveira Coelho Fabri; Ana Paula Mendes Carvalho; Sergio Araujo; Luiz Ricardo Goulart; Ana Márcia Menezes de Mattos; Henrique Couto Teixeira; Isabela Maria Bernardes Goulart; Malcolm S Duthie; Rodrigo Correa-Oliveira; Francisco Carlos Félix Lana Journal: BMC Infect Dis Date: 2015-05-30 Impact factor: 3.090
Authors: Liu Jian; Shang Xiujian; You Yuangang; Xing Yan; Yuan Lianchao; Malcolm S Duthie; Wen Yan Journal: Trans R Soc Trop Med Hyg Date: 2020-02-07 Impact factor: 2.184